chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left-side facial drooping began within 8 hours; feeling dizzy; ntense fatigue; full body aches; Facial numbness; Low fever; chills; heavy heart beat; intermittent cramps of the abdomen and on the left side (between hip and rib cage); Swollen lymph nodes in the neck; constipation; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 11Mar2021 12:15 (lot number: EN6208) as single dose at the age of 39 years old for COVID-19 immunisation. Medical history included allergies: minor reaction to iodine CT contrast. Concomitant medications included fish oil, turmeric [curcuma longa rhizome] (TURMERIC), and xantofyl (LUTEIN); all taken for an unspecified indication, start and stop date were not reported. The patient previously took iodine and experienced allergies (minor reaction to iodine CT contrast). On 11Mar2021 12:45 PM, within an hour of the shot, the patient started feeling dizzy. Intense fatigue and full body aches set in within 3 hours. Facial numbness and left-side facial drooping began within 8 hours. Low fever, chills, heavy heartbeat, and intermittent cramps of the abdomen and on the left side (between hip and rib cage) began within 18 hours. Swollen lymph nodes in the neck and constipation began within 48 hours. Facial numbness, heavy heartbeat, and fatigue persist, though drooping has become less pronounced and the other symptoms have largely resolved at 100 hours since the first shot. Seeking guidance on whether further medical help should be sought (did nurse line call with insurance company) and whether the booster shot should be administered. The AEs resulted in doctor or other healthcare professional office/clinic visit. No treatment was given for the adverse events. The patient has not been tested for COVID post vaccination. The patient was not diagnosed with COVID prior to vaccination. No other vaccines received four weeks prior to COVID vaccination. Outcome of the events was recovered with sequelae.
Patient developed erythema, swelling and warmth over left thigh (where DTaP and Hep A) were given 24 hours after vaccination.  Erythema located on vaccination given on lower part of left thigh, vs higher needlemark.   Patient otherwise without other symptoms.   Treatment included Motrin/Tylenol, Benadryl and icing recommendation.   Redness more confluent when seen for examination on 8/9/06. Still warm to touch.  No limping.
On 9/15/00, the pt received her 1st dose of Havrix and experienced mal-administration (expired vaccine). Additionally, she experienced whole arm pain (injection site). The reporter was told by the CDC that they consider this Havrix dose to be a "non-vaccination". As of 9/21/01, the outcome of the events is resolved.
Given Td on 1/29/2004 in left deltoid area. On 1/31/2004 noted by mom to have swollen, red, hot to touch upper left arm. Went to ER, diagnosed with cellulitis put on Kefzol. Area very sore/itchy.
COVID vaccine vial arrived to facility not reconstituted. Sodium chloride vial to reconstitute vaccine with was packed into separate bag with gloves. Patient was given concentrated dose that was not reconstituted. Vaccine administered at 0845 on 4-7-21 into left deltoid. Patient was monitored for any adverse effects until 1016 and did not have any side effects or adverse events. Administration of facility was notified immediately, upon realization of error and further contact was made with  Pfizer, Pharmacist, and Poison Control and facility chain of command for guidance on handling the issue. Student continues to report no adverse effects and will be contacted by Student Health NP daily for monitoring of any adverse effects. Patient was instructed that his side effects of the vaccine may be intensified due to the increased concentration. Patient was instructed to go to ER, if needed at any point.
After recieving COVID vaccine, pt began experiencing pain in shoulder and chest that radiated down arm.  Pt thought he may be experiencing heart attack, so he went to the ER.   Pt had EKG and CXR which were normal.  Pt states his old injuries (back pain, shoulder pain, meniscus injury) have been much more painful since the vaccine.  Pt also says his sleep apnea has worsened since the vaccine resulting in insomnia.
Information has been received from a nurse practitioner concerning her 27 year old daughter with haemolytic anaemia (requiring blood transfusions every 10 to 12 weeks) and drug hypersensitivity to codeine and a history of splenectomy at 18 months of age and cholecystectomy (December 2007) who on 17-APR-2007, 02-JUN-2007 and October 2007 was vaccinated IM with a first, second and third 0.5 ml dose of GARDASIL. Concomitant therapy included YASMIN, folic acid, PAXIL and vitamins (unspecified). In August 2007, the patient required blood transfusions every 2-3 weeks until March 2008. Since March 2008, the patient has required blood transfusions every 5 to 6 weeks. Laboratory diagnostic studies include a complete blood cell count, liver function tests and reticulocyte count. At the time of this report, the patient had not recovered. Frequent blood transfusions was reported as an other important medical event. Additional information has been requested. 6/20/08-records received-10/05/07-declined tranfusion. LFTs normal. 10/5/07-Feeling sick. Scheduled for cholecystectomy for problems with gall stones and abdominal pain.
I finished the vaccination and immediately after that child developed redness under both eyes. I took Dr. to the room immediately and he examined the patient. She was acting fine except mild redness under both eyes and also in eyes. Dr. spoke to the patient's mother and explained to mother that we will keep her in office to observe her. Dr.  then re-evaluated the patient after 30 minutes and the redness was almost gone. Dr. then discharged the patient and requested mother to give a call if any issues including any breathing complaints. Mother agreed. We spoke to Mother on 11/23/2021 and mother stated that the rashes are going away. I spoke to Mother on 11/24/2021 and per mother she only has a few red dots left on the eyes.
felt like a needle/Pins & needles toes; numbness in toes of his left foot; burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these; stinging, burning sensation, and numbness in toes of his left foot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (felt like a needle/Pins & needles toes), HYPOAESTHESIA (numbness in toes of his left foot), BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) and PAIN (stinging, burning sensation, and numbness in toes of his left foot) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 15-Jun-2015. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCT [HYDROCHLOROTHIAZIDE;LISINOPRIL]) from 15-Jun-2015 to an unknown date, CENTRUM SILVER +50 and COLECALCIFEROL, FISH OIL (FISH OIL + VITAMIN D3) for an unknown indication.    On 24-Jul-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) and PAIN (stinging, burning sensation, and numbness in toes of his left foot). On 03-Aug-2021 at 7:00 AM, the patient experienced PARAESTHESIA (felt like a needle/Pins & needles toes) and HYPOAESTHESIA (numbness in toes of his left foot). On 05-Aug-2021, PARAESTHESIA (felt like a needle/Pins & needles toes), HYPOAESTHESIA (numbness in toes of his left foot) and PAIN (stinging, burning sensation, and numbness in toes of his left foot) had resolved. At the time of the report, BURNING SENSATION (burning sensation, and numbness in toes of his left foot/burning sensation and transitioning back and forth between these) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. Patient did not diagnosed with Covid-19.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Significant FU (ADR Form): medical history, concomitant medication, route and time of vaccine administration updated and events (Paraesthesia and Hypoaesthesia) outcome updated to recovered from recovering. Patient did not diagnosed with Covid-19.
This spontaneous reprot was received from a registered nurse and refers to an unspecified number of patient of unkonwn age and gender. On unknown dates, since 01-JUN-2015, the patients were vaccinated with unspecified number of improperly stored doses of PROQUAD (Merck) lot # K025761. No adverse effects were reported. The outcome of incorrect product storage was unknown. This case was linked to 1507USA010869 and 1507USA004524 as it was received from the same source. Additional information has been requested.
pt fainted, looked yellow, had an irregular pulse (84 beats), & a sz; BP @ 11 was 110/60; ER MD dx syncope; family MD said this was an anaphylactic reaction to Td;
Information was received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2015, the patient was inoculated at a Veteran's outpatient clinic with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain condition of herpes zoster. During 2016, the patient was treated at Outpatient Clinic, for a blistering vesicular outbreak, and decreased immune symptoms which was then diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
past medical history significant for asthma, pulmonary sarcoidosis, hypertension presents to the hospital with fever, cough and worsening dyspnea.  Patient had struggles with asthma exacerbation in February 2021 and since  then has never felt back to her baseline in spite of 3 separate prednisone courses.  Most recently she finished a prednisone course just prior to  this hospitalization.  It is unclear when her symptoms that are specific to COVID-19 started.  Nonetheless she was tested negative for COVID-19 prior to most recent prednisone start but did test positive at this ER visit. Patient admitted for COVID-19 pneumonia associated with acute hypoxic respiratory failure.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in a female patient who received SHINGRIX. Concomitant products included SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain, nausea, muscle weakness, joint pain, headache and drug dose administration interval too short. On an unknown date, the outcome of the pain, nausea, muscle weakness, joint pain, headache and drug dose administration interval too short were unknown. It was unknown if the reporter considered the pain, nausea, muscle weakness, joint pain and headache to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced a reaction after receiving 1st and 2nd dose of SHINGRIX. The patient experienced joint pain, a headache, soreness, nausea, and muscle weakness. The patient received second dose at a shorter than recommended interval at 36 days after the first dose, which led to shortening of the vaccination schedule. This case has been linked with case US2018035442, same patient 2nd dose and US2018GSK040393, reported by the same reporter for the patient.
10 days out from vaccine, developed redness and warmth at the injection site.  No pain, no other concerns.  Just weird this long out from the vaccine.  Redness and warmth is there today.
rash on her left lower back (on top of her left butt), and left thigh/ Rash is very itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash on her left lower back (on top of her left butt), and left thigh/ Rash is very itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (rash on her left lower back (on top of her left butt), and left thigh/ Rash is very itchy). At the time of the report, RASH PRURITIC (rash on her left lower back (on top of her left butt), and left thigh/ Rash is very itchy) outcome was unknown. Not Provided          No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Pulmonary embolism; early pneumonia 1/19/2022 purple hands and feet 103.9 fever short of breath body aches muscle aches 1/18/2022
I suffered a severe local reaction in the arm where the shot was administered. I was unable to move my whole arm, which started at 7:00 pm, four hours after the shot was given. The pain was (on a scale of 1 to 10) past 10. I could not move my arm away from my body. The pain was excruciating, as if my whole shoulder were being pulled backward. That pain lasted for four days. After the fourth day it started getting a little better. After the seventh day I was able to lift my arm all the way up above my head. Today in the ninth day, and has been hurting a little more. There was a little swelling about 3 1/2 inches down from where the shot was administered. Would I ever have that shot again NO.
79 y/o male with history of COPD, Myasthenia Gravis who p/w cough. Patient began to have some sinus symptoms a few days ago. He apparently has had increased cough and has been weak, unable to control his secretions. He came to the ER today, tested positive for covid-19. He is not  hypoxic, he is fully vaccinated and boosted. He notes that he has had a couple of fevers at home. He was started on Augmentin by PCP, has not had a covid test outpatient. CXR clear. Admission requested for treatment with increased weakness of Myasthenia Gravis, neurology has been consulted, patient started on high dose solumedrol.                                             79 y/o male with history of COPD, Myasthenia Gravis who p
Numbness in fingers and toes - tingling sensation - wrist - hand- finger- feet & toes. Weird headache  especially when I sleep.
Prolonged Heavy Mensuration, sometimes with abnormal clotting. Night Sweats several times a week. Constant heart palpitations. Headache, lasting months. Over 10 nose bleeds. Severe vertigo, lasting hours. Constant itchiness on chest.
sore left arm; strange metal taste in her mouth/sugary things may trigger metallic taste/metal taste comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (strange metal taste in her mouth/sugary things may trigger metallic taste/metal taste comes and goes) and VACCINATION SITE PAIN (sore left arm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included Tooth restoration in 2021 and Dental fillings in 2021. Concomitant products included SIMVASTATIN for Cholesterol, LATANOPROST for Glaucoma.    On 15-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore left arm). In 2021, the patient experienced DYSGEUSIA (strange metal taste in her mouth/sugary things may trigger metallic taste/metal taste comes and goes). At the time of the report, DYSGEUSIA (strange metal taste in her mouth/sugary things may trigger metallic taste/metal taste comes and goes) and VACCINATION SITE PAIN (sore left arm) outcome was unknown.            No treatment medications were provided.  Patient stated had dental work in the summer of 2021 (new tooth implant). Patient also reported having another procedure done involving a filling or crown work prior to the dental work done in the Summer 2021. The patient stated she has no known drug or food allergies. The patient mentioned concerned to get the Moderna booster dose.   This case was linked to MOD-2021-380468 (Patient Link).
After getting the vaccine and driving home, one side of my face started to feel like it was getting a little numb. It has stayed the same all day and has not gotten worse. There has been no facial drooping. Also, I have had a metal taste in my mouth.
My son was injected with a 3 days expired MMR Vaccine; This spontaneous report was received from a consumer referring to their son - a male patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with 3 days expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (albumin status, exact dose, route of administration, injection site, lot # and expiration date were not reported) for prophylaxis. The reporter asked if for any advice if there was a possible negative effect and what should they do to counter the effect.
Swollen, feverish left arm. Red, sore. Tried warm and cold compresses, TYLENOL, BENADRYL. No relief.
In late May or early June 2022, I began to have lower back pain and sciatic pain on the right side. I visited with my regular doctor at the end of June. After X-Rays were completed, I was no longer able to work beginning November 2022. I received physical therapy for three months from January 2023-March 2023.
heart arrhythmias; shortness of breath; heart palpitations; This is a spontaneous report from a contactable consumer.   A 58-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications. The patient previously took first dose of bnt162b2 via an unspecified route of administration, on unspecified date (Batch/Lot Number: not reported) as for covid-19 immunization. On an unspecified date, after his 2nd dose, the patient was having shortness of breath, heart palpitations, and heart arrhythmias, not still experiencing them, but experienced after the vaccine. The patient was asking had there been any data or studies on whether to get another or a different vaccine as a booster. Caller states, there will be a time limit on how long these vaccines will be effective. He was concerned about taking a booster shot. The outcome of events was recovered on unspecified date.  Information on the lot/batch number has been requested.
cyst the size of a quarter at the injection site / th issue with the lump in my arm is unique; arm weakness; difficulty raising arm; injection site lump; This case was reported by a consumer via call center representative and described the occurrence of injection site cyst in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (patient had a mild shingles outbreak 14 years and took Valtrex with 72 hours). Previously administered products included Zostavax (received several years ago) and valtrex. Concomitant products included Herpes zoster (Shingrix).   On 22nd May 2019, the patient received the 2nd dose of Shingrix. On 21st December 2019, 213 days after receiving Shingrix, the patient experienced injection site cyst, weakness of arms, injected limb mobility decreased and injection site lump. On an unknown date, the outcome of the injection site cyst, weakness of arms and injected limb mobility decreased were not recovered/not resolved and the outcome of the injection site lump was unknown.   It was unknown if the reporter considered the injection site cyst, weakness of arms, injected limb mobility decreased and injection site lump to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in her left arm and developed a cyst the size of a quarter at the injection site on her left arm that has not gone away. Her physician was recommending that she has the cyst surgically removed. The reporter consented to follow up. The patient received 2nd dose on 22nd May 2019. The patient reported this event to her physician and to Pharmacy. Initially the patient had frustration in talking with staff about my situation. But the more we talked, the more the patient realized that the adverse complaint had not gone to GSK. It went to the FDA. And he did not any way of checking the adverse complaint. And issue with the lump in arm was unique. It was not really reported in the information that GSK gives out, when people get the Shingrix vaccine, like experienced. And the patient had the vaccine early in the marketing of this drug, since the drug started in November of 2018 and got shot in March of 2019. But nonetheless, the more we talked, the more the patient realized that there probably more data but everything was anonymous to protect your privacy. The patient was going back to my doctor next month, to try and see what we can do about the pain and the problem that persists because of shot number one from Shingrix in my left arm.
Upon receiving vaccine patient stated they felt lightheaded and experienced vasovagal syncope within one minute. Patient regained consciousness after several seconds. Patient was given water and a snack after they regained consciousness and asked to remain seated for monitoring . They reported having similar reactions to blood draws in the past.  Patient remained seated for approximately 20-25 minutes and monitored by pharmacist. Afterward he felt back to normal, was able to stand up and ambulate without difficulty or lightheadedness and left.
pt reports 2 days after vaccination noted soreness/ pain below injection site as well as ecchymosis extending from below injection site to just above elbow . pain resolved after few days,  Bruising has presisted
pt recv vax in 6/98 & in 8/98 pt lab work revealed a lack of seroconversion
4/28/2022 Broke out in hives and rashes; began light and got worse. 6/1 sought help from Doctor. Doctor prescribed oral steroids.  This suppressed the outbreak but continues to present less frequently and in smaller patches.
Involuntary jaw and facial muscle clinching, involuntary tongue movement and quivering, diagnosed as oromandibular dystonia.  Treatment w/Trihexyphenidyl not effective & discont'd due to side effects.  As of 11/4/2009 symptoms remaining are tongue movement and quivering--intermittent now, though, rather than continuous.